SCHEMBL2840180

SCHEMBL2840180

Cc1ccc(C(C(=O)NO)c2ccc(N3CCOCC3)cc2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.54
RAB9A P51151 2/20 0.54
TP53 P04637 1/20 0.54
PKM P14618 1/20 0.54
MAPK1 P28482 1/20 0.54
AKR1C3 P42330 1/20 0.54
MAPT P10636 6/20 0.48
ALDH1A1 P00352 4/20 0.48
GAA P10253 2/20 0.48
ADRA1D P25100 1/20 0.48
ADRA1A P35348 1/20 0.48
ADRA1B P35368 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
LMNA P02545 2/20 0.48
USP2 O75604 1/20 0.48
MMP2 P08253 1/20 0.47
MMP9 P14780 1/20 0.47
MMP13 P45452 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2841750 0.87 MAPT (0.48) NPC1RAB9ATP53PKMMAPK1
SCHEMBL2841246 0.87 HDAC8 (0.60) NPC1RAB9APKMAKR1C3MAPT
SCHEMBL2840930 0.86 HDAC8 (0.64) TP53MAPK1AKR1C3MAPTALDH1A1
SCHEMBL2843895 0.84 HDAC3 (0.55) NPC1RAB9AMAPTALDH1A1MEN1
SCHEMBL2838346 0.83 MAPT (0.45) NPC1RAB9AMAPTALDH1A1GAA
SCHEMBL4538504 0.82 HIF1A (0.47) NPC1RAB9APKMAKR1C3MAPT
SCHEMBL2841708 0.82 EPHX2 (0.43) NPC1RAB9ATP53MAPTALDH1A1
SCHEMBL4538436 0.81 MAPT (0.47) NPC1RAB9AMAPTALDH1A1MEN1
SCHEMBL16976240 0.80 HDAC4 (0.64) MAPTMEN1KMT2ALMNAMMP2
SCHEMBL2841130 0.80 HDAC4 (0.64) NPC1RAB9ATP53AKR1C3MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2139850-B1 INHIBITORS OF HISTONE DEACETYLASE METHYLGENE INC (CA) 2018-09-12 EP claimed
EP-2139850-B1 INHIBITORS OF HISTONE DEACETYLASE METHYLGENE INC (CA) 2018-09-12 EP disclosed
US-9096565-B2 Inhibitors of histone deacetylase METHYLGENE INC. (CA) 2015-08-04 US disclosed
US-9096565-B2 Inhibitors of histone deacetylase METHYLGENE INC. (CA) 2015-08-04 US disclosed
US-9096565-B2 Inhibitors of histone deacetylase METHYLGENE INC. (CA) 2015-08-04 US disclosed
EP-2139850-A1 INHIBITORS OF HISTONE DEACETYLASE Methylgene, Inc. (CA) 2010-01-06 EP disclosed
US-20090181943-A1 Inhibitors of Histone Deacetylase METHYLGENE INC. (CA) 2009-07-16 US disclosed
US-20090181943-A1 Inhibitors of Histone Deacetylase METHYLGENE INC. (CA) 2009-07-16 US disclosed
US-20090181943-A1 Inhibitors of Histone Deacetylase METHYLGENE INC. (CA) 2009-07-16 US disclosed
WO-2008122115-A1 INHIBITORS OF HISTONE DEACETYLASE METHYLGENE INC. (CA) 2008-10-16 WO disclosed
WO-2008122115-A1 INHIBITORS OF HISTONE DEACETYLASE METHYLGENE INC. (CA) 2008-10-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090181943-A1 Inhibitors of Histone Deacetylase HDAC1, HDAC11, HDAC3 NPC1 803/4885RAB9A 2699/4885TP53 1559/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.